- Credit Type: CPE
- Credit Amount: 1.00
- Cost: $5.00
- Release: Feb 9, 2015
- Expires: Oct 23, 2017
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Internal Medicine Clinical Pharmacist
UK Chandler Hospital
Needs StatementClostridium difficile infections are a growing problem in US health systems and contributing to increases in morbidity and mortality. Novel treatment strategies are available, but with limited clinical experience the need for further understanding of these strategies will help clinicians mange patients with c. difficile associated diarrhea.
ObjectivesUpon Completion of this activity Pharmacist will be able to:
1. Describe the clinical presentation and morbidity of Clostridium difficile infection
2. Recognize changes in evolving epidemiology and virulence
3. Review current recommendations and challenges in pharmacotherapy
4. Discuss emerging treatment strategies in overcoming disease recurrence
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This knowledge-based activity has been assigned UAN 0022-0000-15-020-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.
Faculty DisclosureHarrison Bachmeier, PharmD (Speaker) has no relevant financial relationships with commercial interests.
Harrison Bachmeier does intend to discuss the off-label use of a product.
No planners have any relevant financial relationships to disclose.
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.